RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 140 filers reported holding RELAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,568 | -39.1% | 8,272 | -9.0% | 0.04% | -38.2% |
| Q2 2023 | $114,196 | +19.8% | 9,092 | +57.1% | 0.07% | +30.8% |
| Q1 2023 | $95,295 | -20.3% | 5,786 | -27.7% | 0.05% | -16.1% |
| Q4 2022 | $119,580 | -28.8% | 8,004 | +6.4% | 0.06% | -7.5% |
| Q3 2022 | $168,000 | +34.4% | 7,526 | +0.7% | 0.07% | +45.7% |
| Q2 2022 | $125,000 | -24.7% | 7,476 | +34.5% | 0.05% | -37.8% |
| Q1 2022 | $166,000 | -8.3% | 5,558 | -5.6% | 0.07% | +8.8% |
| Q4 2021 | $181,000 | -7.7% | 5,885 | -5.3% | 0.07% | -20.9% |
| Q3 2021 | $196,000 | -18.0% | 6,213 | -5.1% | 0.09% | -12.2% |
| Q2 2021 | $239,000 | +0.8% | 6,544 | -4.5% | 0.10% | -2.0% |
| Q1 2021 | $237,000 | -15.4% | 6,849 | +1.7% | 0.10% | -13.8% |
| Q4 2020 | $280,000 | – | 6,732 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |